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Abstract
Background: Cultured spinal motor neurons are a valuable tool to study basic mechanisms of development, axon 
growth and pathfinding, and, importantly, to analyze the pathomechanisms underlying motor neuron diseases. 
However, the application of this cell culture model is limited by the lack of efficient gene transfer techniques which are 
available for other neurons. To address this problem, we have established magnetofection as a novel method for the 
simple and efficient transfection of mouse embryonic motor neurons. This technique allows for the study of the effects 
of gene expression and silencing on the development and survival of motor neurons.
Results: We found that magnetofection, a novel transfection technology based on the delivery of DNA-coated 
magnetic nanobeads, can be used to transfect primary motor neurons. Therefore, in order to use this method as a new 
tool for studying the localization and transport of axonal proteins, we optimized conditions and determined 
parameters for efficient transfection rates of >45% while minimizing toxic effects on survival and morphology. To 
demonstrate the potential of this method, we have used transfection with plasmids encoding fluorescent fusion-
proteins to show for the first time that the spinal muscular atrophy-disease protein Smn is actively transported along 
axons of live primary motor neurons, supporting an axon-specific role for Smn that is different from its canonical 
function in mRNA splicing. We were also able to show the suitability of magnetofection for gene knockdown with 
shRNA-based constructs by significantly reducing Smn levels in both cell bodies and axons, opening new 
opportunities for the study of the function of axonal proteins in motor neurons.
Conclusions: In this study we have established an optimized magnetofection protocol as a novel transfection method 
for primary motor neurons that is simple, efficient and non-toxic. We anticipate that this novel approach will have a 
broad applicability in the study of motor neuron development, axonal trafficking, and molecular mechanisms of motor 
neuron diseases.
Background
Motor neuron diseases are a group of lethal neurological
disorders with different etiologies and clinical variability
that have one characteristic in common: the selective
degeneration of motor neurons, a small population of
cells within the central nervous system with a highly spe-
cialized morphology and function [1]. To study the selec-
tive vulnerability of motor neurons in these diseases,
isolated primary motor neurons, either cultured pure or
in co-culture with glia or muscle cells, have been estab-
lished as an important in vitro model. Studies on cultured
spinal cord motor neurons have made important contri-
butions to our understanding of motor neuron neurobiol-
ogy, such as the identification of neurotrophic factors
that regulate survival, regeneration and plasticity [2,3].
However, functional studies in primary motor neurons
have been hampered by the lack of reliable and efficient
transfection protocols to enable not only protein overex-
pression, but also gene knockdown with shRNA con-
structs. Currently, the only method with acceptable
transfection efficiency is transduction with lentiviral vec-
tors, which has some limitations (e.g. size of the insert),
and is both time consuming and requires additional
safety precautions and special equipment [4,5]. A repre-
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in vitro studies have been performed in immortalized cell
lines is spinal muscular atrophy (SMA). SMA is caused by
mutations or gene deletions in the survival of motor neu-
ron (SMN1) gene encoding the ubiquitously expressed
SMN protein [6-8]. SMN has a critical housekeeping
function in the correct assembly of spliceosomal small
nuclear ribonucleoproteins (snRNPs) [9]. It is a major
conundrum in SMA research how a reduction in levels of
the ubiquitously expressed and essential SMN protein in
all tissues selectively affects motor neurons. Since SMN-
containing granules have been found to be actively trans-
ported in processes and growth cones of chick forebrain
neurons [10] and axonal defects have been observed in
SMA animal models [11,12], we and others have pro-
posed an additional role for SMN in the axon that may
contribute to the unique vulnerability of motor neurons
to low levels of SMN protein [7,8,13-15]. However,
expression of fluorescent-tagged SMN protein has never
been used as a complementary approach to immunofluo-
rescence in motor neurons, and SMN trafficking has
never been studied in axons of live primary motor neu-
rons before. To address these limitations of motor neuron
cell culture models, we have established magnetofection
as a novel tool for the reliable, rapid and efficient non-
viral transfection of embryonic primary motor neurons.
In the magnetofection method, DNA aggregated with
superparamagnetic iron oxide nanoparticles is deposited
on target cells by the application of a magnetic field and
taken up via endocytosis [16].
We have carefully optimized the time course, media,
and reagent concentration for primary motor neurons to
routinely achieve transfection efficiencies higher than
45%. Importantly, survival and morphology of the trans-
fected motor neurons were not altered. Magnetofection
allows both efficient overexpression and knockdown of
the gene of interest to study the effects of both toxic gain
of function and loss of function on the differentiation and
survival of primary motor neurons.
Using this method, we have shown for the first time the
active transport of the survival of motor neuron (SMN)
protein along the axon of live primary motor neurons.
The described method has not been used in motor neu-
rons before and represents a powerful new tool to study
the role of proteins implicated in SMA and other motor
neuron diseases in the very cell type that is primarily
affected by these disorders.
Results and Discussion
Primary motor neurons can be efficiently transfected with 
magnetic nanobeads
In an effort to overcome fundamental limitations of viral
and non-viral gene transfer into primary cultured motor
neurons, we have tested transfection with magnetic
nanobeads (magnetofection), a method that has been
previously used on primary hippocampal neurons [17].
Postmitotic neurons are sensitive to cytotoxicity and dif-
ficult to transfect. This is especially true for primary
motor neurons, in which the efficiency of conventional
transfection techniques (i.e. liposomes, electroporation)
is far too low for most applications or the transfection
procedures are cytotoxic, inducing morphological
changes and cell death. Whereas in hippocampal neurons
several transfection methods such as nucleofection [18],
liposomes [19], Polyethylenimine [20] and Ca(2+)-phos-
phate [21] have been established, currently there is no
efficient method for the transfection of primary motor
neurons available.
To test the efficiency of magnetofection on primary
motor neurons, we performed preliminary experiments
transfecting a plasmid encoding a variant of green fluo-
rescent protein (pmaxGFP) into 2 DIV primary motor
neurons, the stage at which the motor neuron axon is still
actively growing. In order to maximize transfection effi-
ciency, we varied the total DNA amount used, ranging
from 0.5 μg to 2 μg, but we kept the DNA:beads ratio con-
stant (1:3.5). Cells were fixed 48 hours post transfection
and stained for neurofilament and the motor neuron spe-
cific marker HB9. Whole 15 mm coverslips were imaged
and the percentage of GFP-positive motor neurons was
evaluated under different conditions (Fig. 1A). By lower-
ing the DNA amount to 0.5 μg, we achieved transfection
efficiencies higher than 45% (Fig. 1B). However, further
reducing DNA levels down to 0.125 μg did not prove ben-
eficial, decreasing the percentage of transfected cells to
less than 30%. Since motor neurons are cultured in Neu-
robasal medium, we decided to compare it with minimal
essential medium (MEM) during the DNA/beads com-
plex formation. Surprisingly, we found that using Neu-
robasal medium during DNA/beads complex formation
resulted in very low transfection efficiencies for motor
neurons (Fig. 1C).
The ability to transfect motor neurons at different days
after plating is very important for studying the effect of
expressing a specific protein during the initial phase of
axon outgrowth or in more mature neurons. To assess
whether our method would be suitable for this applica-
tion, we transfected the pmaxGFP plasmid into young (0
and 1 DIV) and more mature (7 DIV) cultures. While the
magnetofection of motor neurons at the time of plating (0
DIV) resulted in high toxicity and cell death (data not
shown), both 1 DIV and 7 DIV motor neurons were effi-
ciently transfected using our protocol, although with a
lower efficiency than 2 DIV cultures (Fig. 2).
Taken together, these data show that the use of para-
magnetic nanobeads represents a new and highly effi-
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neurons at different stages of differentiation and matura-
tion. On average, two thirds of the cells obtained from
one single lumbar spinal cord were used per magnetofec-
tion. Using coverslips smaller than 15 mm would further
reduce the required cell number. Importantly, this shows
that our protocol works with low cell numbers and there-
fore can be used to perform multiple transfections of
motor neurons from single mouse embryos, for example
to compare the effect of gene expression in wild type and
knockout motor neurons.
Primary motor neurons show normal morphology and 
survival after magnetofection
In parallel to quantifying transfection efficiencies, we
investigated potential direct toxic effects or cell mem-
brane perturbations caused by the magnetic beads, that
could cause changes to cell morphology and survival.
Magnetic nanoparticles are made of biodegradable iron
oxide with a polymer coating and have been shown in
other cell types to be non-toxic and not to influence cel-
lular functions [17,22-24]. Primary motor neurons, how-
ever, are especially sensitive to changes to the
Figure 1 Magnetofection of primary motor neurons is highly efficient. Primary motor neurons (2 DIV) were transfected with pmaxGFP using 
magnetic nanobeads. Different amounts of DNA and beads and different media were tested to optimize transfection efficiency. Cells were fixed 2 days 
post transfection and stained using neurofilament (NF) and HB9 antibodies to identify motor neurons. A. Representative image of a motor neuron 
culture from an entire 15 mm diameter coverslip. B. GFP/HB9+ cells were scored and normalized to the number of HB9+ cells. Maximum efficiency of 
transfection (46%) was achieved using 0.5 μg DNA and 1.75 μl beads (mean and SEM, n = 3). C. Neurobasal medium inhibited motor neuron transfec-
tion when used during DNA/beads complex formation. MEM is shown as a positive control. Size bars: 1 mm in A, 50 μm in B.
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than other cell types.
In order to investigate changes in cell morphology
caused by magnetofection, we transfected motor neurons
with a plasmid encoding the F-actin reporter Lifeact-GFP
[25]. The Lifeact peptide has been shown to bind actin fil-
aments in vivo without affecting their dynamics. Cells
were fixed 24 hours after transfection, and the morphol-
ogy of the cell body, dendrites, and axonal growth cone
was compared with untransfected cells stained with the
fluorescently labeled F-actin probe rhodamine phalloidin
(Fig. 3A). No obvious changes in any of the cell compart-
ments analyzed were observed. We then investigated
whether survival of motor neurons was affected by the
delivery of the magnetic beads. For this purpose, cells
were transfected with the pmaxGFP plasmid and fixed 3
and 5 days post transfection. When we compared the
number of HB9-positive neurons in transfected and
untransfected cultures, we did not observe any differ-
ences (Fig. 3B). Importantly, the percentage of GFP-posi-
tive motor neurons did not decrease over the course of 5
days (46.2 ± 6.7% and 43.13 ± 5.17% at day 3 and 5,
respectively) confirming the low toxicity of the transfec-
tion method.
Taken together, these data demonstrate that motor
neurons can be efficiently transfected without a negative
impact on their survival and morphology, and that gene
expression persists at a high level several days after trans-
fection, establishing the magnetofection method as a
valuable tool for studying motor neuron biology.
Several constructs can be co-transfected efficiently into 
primary motor neurons
One of the main limitations of virus transduction is the
difficulty to co-deliver several constructs into the same
cell due to viral interference [26]. To address the possibil-
ity to overcome this limitation using our method, we
transfected motor neurons with three different plasmids
encoding for the soluble red fluorescent protein mCherry
[27], the F-actin binding fusion protein Lifeact-GFP [25],
and the nuclear-targeted blue fluorescent protein EBFP2-
Nuc [28]. All transfected motor neurons showed expres-
sion of all three proteins correctly localized to different
cell compartments (Fig. 4). This result demonstrates that
the co-expression of at least three proteins in the same
cell is feasible. Taken together our data support magneto-
fection as a very useful alternative to viral transduction. It
also has several important advantages: it is more repro-
ducible and less time consuming because it does not
depend on cloning into transfer vectors, packaging into
viral particles, and determining the lentivirus titers. Also,
there is no size limit on the insert size of the plasmid and
efficient co-transfection of several constructs into one
cell is not affected by viral interference [26]. Additionally,
unlike the delay observed with viral transduction, high
expression levels can be achieved as early as one day after
transfection.
Axonal localization and bi-directional axonal transport of 
Smn in transfected motor neurons
As of now, the vast majority of studies on SMN function
have been performed in non-neuronal cells (i.e. fibro-
blasts) that do not represent the cell population affected
in SMA. Due to the lack of reliable transfection methods,
SMN localization and trafficking using fluorescent
reporters has yet to be studied in motor neurons.
For this reason, we decided to apply our novel method
to the study of the localization of murine Smn in the
axons of primary motor neurons. For this purpose, we
used both N- and C- terminal fusions of full length Smn
with EGFP and mCherry proteins. In all tested combina-
tions, Smn protein localized to nuclear foci, called gems,
and to small granules in the cytoplasm, and along the
dendrites and axons of primary motor neurons (Fig. 5A),
well in agreement with the localization of the endogenous
Smn protein [8,13,15].
Since our results have shown that magnetofection has
no apparent toxic effect on motor neurons, we attempted
to use this method for studying the axonal transport of
Smn. Performing successful live-cell imaging experiments
demands that the cells remain in a healthy state and that
cell morphology and function are preserved during
examination under the fluorescence microscope. To
study trafficking of Smn-containing granules in the axon
Figure 2 Young and mature motor neuron cultures are efficiently 
transfected by magnetofection. 1 DIV (top), 2 DIV (middle), and 7 DIV 
(bottom) motor neurons were transfected with pmaxGFP. Twenty-four 
hours after transfection cells were fixed and stained with neurofila-
ment antibody to identify neurons (NF, red). DAPI was used to stain nu-
clei (blue). GFP-positive cells (green) are visible in all tested conditions. 
Size bars: 100 μm.
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construct for Smn tagged with mCherry into primary
motor neurons. In order to increase the chances to
observe moving granules, cells were starved with
medium lacking trophic factors before adding complete
glia-conditioned imaging medium supplemented with
100 μM of the cell-permeable cAMP analogue 8-Bromo-
cAMP, a paradigm known to stimulate β-actin mRNA
granule transport [29]. Using time-lapse video micros-
copy, we could show for the first time that Smn is actively
transported in axons of primary motor neurons, both
retro- and anterogradely (Fig. 5B and additional file 1).
Smn-containing granules moved at a speed of 2.32 ± 0.7
μm/sec. No differences were observed between particles
moving anterogradely toward the growth cone (2.21 ±
0.37 μm/sec; n = 5) or retrogradely toward the cell body
(2.46 ± 1.02 μm/sec; n = 4). These results show that mag-
netofection can meet the technical challenges presented
by live cell imaging and allow for analysis of axonal pro-
tein transport in primary motor neurons.
Magnetofection can be used to silence gene expression
One of most powerful approaches to study the function
of a protein is to knockdown its expression with siRNA
technology. The efficiency of gene transfer using our pro-
tocol prompted us to investigate the possibility not only
to overexpress a gene product, but also to silence its
expression using a vector-based approach. For this pur-
pose, we transfected motor neurons either with an
shRNA vector targeting Smn mRNA or a non-silencing
control. Cells were fixed after 5 days, and stained for
endogenous Smn protein. Transfected cells expressing
the shRNA construct, identified by GFP expression,
showed a significant reduction in endogenous Smn pro-
tein levels in cell bodies and axons by 40.6% and 36.2%,
respectively, when compared to the non-silencing control
shRNA vector (Fig. 6). Our results show that expression
from transfected plasmids was strongly visible at 12 h
after transfection and persisted at a high level several
days after transfection allowing gene silencing by shRNA
technology. Importantly, we can show reduced levels of
Smn not only in the cell body, but also in the axonal com-
partment, allowing investigations of the axonal function
of specific genes and proteins in primary motor neurons.
Our results demonstrate that magnetofection is a useful
tool to study the role of specific proteins in axons of pri-
mary motor neurons.
Conclusions
In this study we have established magnetofection as a
novel method for the transfection of primary motor neu-
rons that is efficient, robust and non-toxic. It is cost-
Figure 3 Magnetofection does not affect motor neuron morphology and survival. Primary motor neurons (2 DIV) were transfected with Lifeact-
GFP (A) or pmaxGFP (B) and fixed 1 day (A), or 3 and 5 days (B) after transfection. A. Motor neuron morphology was evaluated using the F-actin probe 
Lifeact-GFP and compared to rhodamine phalloidin staining. Cell body, dendrites (left) and growth cone (right) did not show any difference between 
transfected (top panel) and control (bottom) cells. Size bar: 10 μm. B. Surviving motor neurons were scored based on neurofilament (NF) and HB9 stain-
ing (left). Representative images are shown (bottom right). Bars represent mean and SEM from 3 independent experiments. One way repeated mea-
sures ANOVA, p > 0.05.
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ized equipment. Our optimized protocol allows for effi-
cient transfection of motor neurons during different
stages of maturation, high levels of expression over sev-
eral days, and the co-expression of at least three proteins
in one cell.
To test the application of this promising new method,
we have for the first time overexpressed and knocked-
down the SMA disease protein Smn in the cell body and
axon of motor neurons. We have also shown for the first
time the active transport of Smn-containing granules
along motor neuron axons anterogradely and retro-
gradely with a speed consistent with fast axonal trans-
port.
We anticipate that this efficient transfection method for
primary motor neurons and its applications described in
this study will also have more general applications in neu-
rodegeneration research. We expect that this approach
will facilitate the research on pathways regulating motor
neuron development and survival as well as molecular
mechanisms underlying motor neuron disease.
Methods
Embryonic primary motor neuron culture
C57BL6 timed pregnant mice (Charles Rivers) were sacri-
ficed following the protocol approved by the Institutional
Animal Care and Use Committee (IACUC) at Emory
University. Primary motor neurons from E13.5 mouse
embryos were isolated and cultured essentially as
described [30,31], but the magnetic column step was
omitted, and 6% Optiprep (Sigma) was used for gradient
centrifugation. Glia cells obtained from embryonal spinal
cords after motor neuron isolation were grown in MEM,
10%FBS, 10 mM Hepes, 33 mM glucose. Secondary glia
cells were incubated with motor neuron culture medium
(Neurobasal, 0.5 mM Glutamax, 2% B27; Invitrogen) for
one day to obtain glia-conditioned media. Motor neurons
were plated on 15 mm coverslips (Assistant cover glasses;
Carolina) coated with 0.5 mg/ml poly-ornithine (MW 30-
70 KDa; Sigma) and 0.5 mg/ml laminin (Invitrogen), and
cultured in glia-conditioned Neurobasal/B27 medium
supplemented with 2% horse serum (Sigma), and 10 ng/
ml each BDNF, CNTF, and GDNF (Peprotech).
Magnetofection of primary motor neurons
Motor neurons (2 DIV) were transfected using paramag-
netic nanobeads (NeuroMag, Oz Biosciences) as follows:
complete medium was replaced 1 hour prior to magneto-
fection with serum-free glia-conditioned Neurobasal/B27
medium. Plasmid DNA (0.5 μg) was incubated with 1.75
μl NeuroMag beads in 100 μl minimal essential medium
(MEM) for 15 minutes, and then added drop-wise to the
cultures. Cells were incubated on top of a magnetic plate
(Oz Biosciences) for 15 minutes and complete medium
was restored after 1 hour.
Constructs
mCherry [27], Lifeact-GFP [25] and pEBFP2-Nuc [28]
were kindly provided by Dr. Roger Tsien (UCSD, USA),
Figure 4 Magnetofection allows high-efficient transfection using multiple constructs. Primary motor neurons were transfected using three dif-
ferent constructs coding for the F-actin binding protein Lifeact fused to GFP, the soluble red fluorescent protein mCherry, and the nuclear localized 
blue fluorescent protein EBFP2-Nuc. A. All transfected cells expressed all three fluorescent proteins. B. High magnification shows the different subcel-
lular localization of all three proteins in the same cell. Background dots in the red and blue channels are due to remaining autofluorescent beads. Size 
bars: 200 μm in A and 10 μm in B.
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Figure 5 Fluorescent protein-tagged Smn is localized and actively transported in the axons of primary motor neurons after magnetofec-
tion. A. Full-length Smn fused to the N- (top) or C-terminus (bottom) of EGFP or mCherry fluorescent proteins (FP) was tested in order to exclude ar-
tefacts caused by the fusion partner. Compressed deconvolved 3-D image stacks show Smn-positive gems in the nucleus (arrows) and small granules 
localized along the axon (arrowheads). DAPI staining (blue) identifies nuclei. B. Live cell imaging of Smn-mCherry granules. Single snapshots of a rep-
resentative Smn-positive granule moving anterogradely toward the growth cone (star) are shown. The granule moved 50.05 μm with an average 
speed of 1.80 μm/sec. Size bars: 10 μm in A, 15 μm in B.
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and Dr. Campbell (University of Alberta, Canada;
Addgene plasmid #14893). The pmaxGFP vector was
from Lonza. The SMN (V2LMM_6035) and control
(RHS4346) shRNA vectors were from Open Biosystems.
Green (EGFP) or red (mCherry) fluorescent proteins
were fused N- or C-terminal to Smn. A flexible liker
[(SGGG)3] was inserted between the fusion partners to
facilitate correct protein folding. A point mutation was
introduced (A206K) to generate monomeric forms of
GFP as described [32].
Cell staining and imaging
Magnetofected motor neurons were fixed for 15 minutes
with 4% paraformaldehyde 24 hours to 5 days after trans-
fection, as indicated. Anti- neurofilament (1:500; 2H3,
DHSB), HB9 (1:5000; Abcam), and SMN (1:500; BD) anti-
bodies were incubated overnight at 4°C. Rhodamine-con-
jugated phalloidin (1:500; Invitrogen), and Cy3-, Cy2- or
Cy5-conjugated secondary antibodies were incubated for
1 hour at room temperature. Cells were imaged using a
widefield microscope (TE300, Nikon) equipped with a
high resolution CCD camera (Quantix, Photometrics).
Image stacks were deconvolved (Autodeblur, Media
Cybernetics) and analyzed using the Imaris software (Bit-
plane). Entire 15 mm coverslips were scanned using a
motorized confocal microscope (LSM 510, Zeiss). The
2H3 antibody developed by Dr. Jessell was obtained from
the Developmental Studies Hybridoma Bank (DSHB)
developed under the auspices of the NICHD and main-
Figure 6 Smn knockdown in primary cultured motor neurons after magnetofection with an shRNA construct. Primary motor neurons were 
transfected with an Smn-specific (top) or control shRNA plasmid (bottom) for 5 days. Transfected cells were identified by EGFP expression (green). Anti-
Smn antibody staining (red) was used to evaluate Smn protein levels. Fluorescence intensity was quantified in the cell body and axon using the Imaris 
software and normalized to the axon volume. Smn protein levels were reduced in both cell body and axon when the Smn-specific shRNA was used, 
in comparison to the control shRNA construct. Bars represent mean and SEM. One way ANOVA, n = 3; ***p < 0.001, **p < 0.01. Size bar: 10 μm.
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Iowa City, IA 52242.
Life cell imaging
Motor neurons were plated on poly-ornithine/laminin
coated Delta T culture dishes (Bioptechs). Twenty-four
hours after transfection, cells were starved in plain Neu-
robasal medium for 30 minutes and then stimulated for
15 minutes with 100 μM 8-Bromo-cAMP (Calbiochem)
in glia-conditioned imaging medium (Hibernate E low
fluorescence, Brain Bits) supplemented with 2% B27 and
2% horse serum. Movies were acquired using a widefield
epifluorescence microscope (TE2000, Nikon) with a high
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